Trademark applications and grants for Outlook Therapeutics Inc. Outlook Therapeutics Inc has 8 trademark applications. The latest application filed is for "LYTENAVA"
Patent Application | Date |
---|---|
BUFFERED FORMULATIONS OF BEVACIZUMAB FOR USE OF TREATING DISEASES 20210230261 - 17/048107 YONAN; Chris ;   et al. | 2021-07-29 |
MODULATION OF AFUCOSYLATED SPECIES IN A MONOCLONAL ANTIBODY COMPOSITION 20190161543 - 16/067193 SANTORO; Marc ;   et al. | 2019-05-30 |
SEC | 0001649989 | Outlook Therapeutics, Inc. of DELAWARE |
SEC | 1649989 | Outlook Therapeutics, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.